Two Sigma Securities, LLC Bio Cardia, Inc. Transaction History

Two Sigma Securities, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.38 - $0.68 $42,210 - $75,533	111,079 New	111,079 $45,000
Q1 2022 May 16, 2022	SELL	$21.3 - $39.0 $451,474 - $826,644	-21,196 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.65 - $46.05 $543,677 - $976,075	21,196 New	21,196 $41,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $39.8M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.